Streetbeat News

Stock Prices

MODN

Over the past 3 months, 7 Wall Street analysts have provided ratings for Model N (NYSE:MODN), with 3 bullish, 2 somewhat bullish, and 2 indifferent. The average 12-month price target is $32.14, with a high of $37.00 and a low of $25.00. This target has decreased by 16.67% from the previous target of $38.57. Analyst ratings are based on company data, financial statements, and insider information, but are subject to human error.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 2:00 pm

COST

Costco Wholesale (NASDAQ:COST) is scheduled to release its quarterly earnings report on Thursday, 2023-12-14. Analysts predict an EPS of $3.41. Investors are looking for an earnings beat and positive guidance for future growth. Historically, Costco has had mixed post-earnings stock price movements. Shares are currently at $629.5, up 36.02% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 2:00 pm

RXST

Over the past 3 months, 4 Wall Street analysts have provided ratings on RxSight (NASDAQ:RXST), with 2 giving a bullish and 2 a somewhat bullish outlook. The average price target among them is $37.0, which is below the current price of $38.5, suggesting a downside. The average price target has increased by 2.78% over the past month. Analysts typically review stocks quarterly or after major company updates, using financial predictions and company performance to guide their ratings.

Portfolio Pulse from Benzinga Insights

December 13, 2023 | 2:00 pm

CCCC

C4 Therapeutics' stock price has increased following the announcement of positive data from their CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:58 pm

NVDA

TSM

Nvidia has reportedly placed orders with TSMC for AI processors destined for China, which require SHR technology. Fulfillment is expected to begin in Q1 2024, as per industry sources cited by DigiTimes.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:57 pm

TLRY

Tilray Brands, Inc. (NASDAQ: TLRY) announced the release of three new cannabis-infused tea blends from its wellness brand, Solei. The new teas include Decaffeinated Jasmine Green Tea, Spiced Starlight, and Chai Rooibos, each containing varying amounts of CBD, CBN, and THC. The announcement comes as Tilray's shares traded slightly lower at $1.79 per share during the pre-market session on Wednesday. The article also mentions the performance of other cannabis stocks and the potential for growth in the sector.

Portfolio Pulse from Jelena Martinovic

December 13, 2023 | 1:52 pm

SPRC

SciSparc shares have seen an increase in trading activity following the announcement of positive results for MitoCareX Bio using its drug discovery platform.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:49 pm

CCCC

SPRC

STTK

Shattuck Labs (STTK) reported positive initial topline data from a Phase 1 clinical trial of SL-172154, leading to a 246% surge in its stock. SciSparc (SPRC) announced that MitoCareX Bio met its second milestone in a joint venture, resulting in a 73% stock increase. C4 Therapeutics (CCCC) was upgraded to Buy by Stifel with a new price target of $12, causing a 46% rise in its share price.

Portfolio Pulse from ryanfaloona@benzinga.com

December 13, 2023 | 1:46 pm

RSLS

ReShape Lifesciences Inc. (RSLS) stock is trading higher following the announcement that the company has received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:46 pm

STTK

Shattuck Labs' stock price has increased following the announcement of positive initial topline dose-expansion data from its Phase 1A/B clinical trial of SL-172154, used in combination with AZA to treat HR-MDS and TP53m AML patients.

Portfolio Pulse from Benzinga Newsdesk

December 13, 2023 | 1:45 pm